Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistant to Multiple 2′,3′-Dideoxynucleoside 5′-Triphosphates
Open Access
- 1 October 1995
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 270 (40), 23605-23611
- https://doi.org/10.1074/jbc.270.40.23605
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Zidovudine Resistance and HIV-1 Disease Progression during Antiretroviral TherapyAnnals of Internal Medicine, 1995
- HIV resistance to reverse transcriptase inhibitorsBiochemical Pharmacology, 1994
- Identification of the amino acid in the human immunodeficiency virus type 1 reverse transcriptase involved in the pyrophosphate binding of antiviral nucleoside triphosphate analogs and phosphonoformateBiochemical Pharmacology, 1993
- A Mutation in Human Immunodeficiency Virus Reverse Transcriptase and Decline in CD4 Lymphocyte Numbers in Long-Term Zidovudine RecipientsThe Journal of Infectious Diseases, 1993
- Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT TrialAIDS, 1993
- Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.Proceedings of the National Academy of Sciences, 1993
- Fidelity of HIV-1 reverse transcriptase copying RNA in vitroBiochemistry, 1992
- HIV-1 sensitivity to zidovudine and clinical outcome in childrenThe Lancet, 1992
- The Accuracy of Reverse Transcriptase from HIV-1Science, 1988
- Fidelity of HIV-1 Reverse TranscriptaseScience, 1988